Course description
Life sciences professionals, whether they spend their day-to-day in the lab or behind a desk, need to maintain excellence in their own expertise as well as understand the role they play in their organization’s overall business and operational environments. Definitions of success are shifting, impacted by scientific advancement, ongoing regulatory developments, and the globalization of supply and distribution.
The Mini-MBA in BioPharma Innovation teaches life sciences experts key business management theory and methodology that will broaden their perspective. This course provides a better understanding of how biopharma companies plan for, and profit from, constant innovation.
Do you work at this company and want to update this page?
Is there out-of-date information about your company or courses published here? Fill out this form to get in touch with us.
Who should attend?
The Mini-MBA in BioPharma Innovation program is an excellent fit for those with considerable experience or advanced degrees in the traditional sciences, and the intellectual curiosity and professional ambition to acquire complementary business management skills.
Those coming from outside of life sciences, or within life sciences but outside of the laboratory, will find this a unique opportunity to learn key business concepts and understand how life sciences companies endeavor to merge excellent science with effective business practices.
Training content
Featuring 10 modules (each covered in 3.5 hours), this program empowers biotechnology and pharmaceutical professionals to use business strategies and methods to complement achievement in scientific study, with multidisciplinary contributions and thought leadership.
Topics include:
- Modeling the Return in Investment in Research and Development. Learn the financial models and methods that corporate decision makers apply, including discounted cash flow models, net present value, and internal rates of return.
- Strategic Alliances and Acquisitions.Analyze the role of partnering and mergers from a strategic perspective, including the financial and managerial challenges incumbent in the uncertainties specific to drug and biotech discovery and development.
- Innovation in the Pharmaceutical and Biotechnology Industries. Learn how the psychology of decision-making, organizational structure, and corporate culture influence stakeholders’ decisions, and its impact on R&D funding.
Course delivery details
- 03 Feb-28 Apr 2022: Self-Paced 12 Week Program
- 03 May-02 Jun 2022 Tues & Thurs 9AM - 12PM. Synchronous 5 Week
Contact this provider
Rutgers Business School | Resilient. Resourceful.
Founded in 1929, Rutgers Business School has a rich history in the state of New Jersey -- a history deeply embedded in the larger story of Rutgers University-Newark and Rutgers University-New Brunswick. Rutgers University. Rutgers has been revolutionary for 250...